Universal Technical Institute Reports Fiscal Year 2023 First Quarter Results
Universal Technical Institute (UTI) reported financial results for Q1 FY2023, revealing revenues of $120 million, up 14.2% year-over-year, attributed largely to the acquisition of Concorde Career Colleges, which contributed $14.4 million. However, net income fell to $2.6 million from $14.8 million in the prior year. Operating expenses increased by 26.3% to $115.6 million. UTI reaffirmed its full-year guidance, aiming for revenues exceeding $700 million and Adjusted EBITDA approaching $100 million in FY2024. Despite challenges, UTI remains optimistic about future growth, including plans for new programs and ongoing integration of Concorde.
- Revenues increased 14.2% to $120 million.
- Reaffirmed full-year guidance with revenues expected to exceed $700 million in FY2024.
- Successful integration of Concorde with smooth operations across seventeen campuses.
- Net income fell to $2.6 million from $14.8 million year-over-year.
- Operating expenses rose by 26.3% to $115.6 million.
- Adjusted EBITDA decreased to $14.4 million compared to $20.6 million in the previous year.
- Revenue was
with Concorde contributing$120.0 million .$14.4 million - Net income of
, adjusted net income* of$2.6 million , and adjusted EBITDA* of$5.3 million .$14.4 million - Total new student starts of 2,310 with 336 contributed by Concorde.
- The performance was in line with expectations and therefore the Company reaffirms its full year guidance across all key metrics.
- The Company's current period results include Concorde for the month of December reflecting the
December 1, 2022 closing date of the acquisition. Total company year-over-year comparisons are shown on an "as-reported basis," consistent with the Company's previously provided fiscal 2023 guidance.
"We are off to a positive start and 2023 promises to be a pivotal year for the Company," noted
Grant continued, "UTI is focused on executing both the core business objectives in a challenging macroeconomic environment, as well as bringing its two new campuses in
Financial Results for the Three-Month Period Ended
- Revenues increased
14.2% to compared to$120.0 million primarily due to the addition of Concorde.$105.1 million - Operating expenses rose by
26.3% to , compared to$115.6 million . The increase was primarily due to the acquisition of Concorde, incremental cost of delivery associated with UTI new campus and program rollouts in the prior year, and both one-time and ongoing investments in support of our growth and diversification strategy.$91.5 million - Operating income was
compared to$4.4 million .$13.6 million - Net income was
compared to$2.6 million . Adjusted net income* was$14.8 million compared to$5.3 million .$15.4 million - Basic earnings per share (EPS) was
compared to$0.03 , and diluted EPS was$0.25 compared to$0.02 .$0.25 - Adjusted EBITDA* was
compared to$14.4 million .$20.6 million
UTI
- UTI had revenues of
, slightly above the prior year quarter revenues of$105.6 million .$105.1 million - Operating expenses for UTI were
, compared to$89.1 million . The increase was primarily due to higher compensation related and other expenses incurred during the current year due to the new campuses and welding programs launched in the prior year, along with costs for incremental advertising and admissions resources to support growth objectives for the segment.$81.9 million - Adjusted EBITDA* was
compared to$23.3 million .$28.7 million - New student starts were flat to the prior year, while average undergraduate full-time active students decreased
1.6% .
Concorde (for the month of
- Revenues of
. Of note, due to seasonality and phasing of clinical programs, December is one of the lowest revenue months of the year.$14.4 million - Operating expenses were
.$15.2 million - Adjusted EBITDA* was
.$(0.1) million - New student starts of 336 and 7,737 average undergraduate full-time active students.
*See "Use of Non-GAAP Financial Information" below.
"We are pleased with our first quarter results, which were driven by solid execution and diligent expense management," said
Balance Sheet and Liquidity
At
Student Metrics
Three Months Ended | |||||
UTI | Concorde | Total | |||
Total new student starts | 1,974 | 336 | 2,310 | ||
Average undergraduate full-time active students | 13,511 | 7,737 | 21,248 | ||
End of period undergraduate full-time active students | 12,657 | 7,630 | 20,287 | ||
Three Months Ended | |||||
UTI | Concorde | Total | |||
Total new student starts | 1,972 | — | 1,972 | ||
Average undergraduate full-time active students | 13,729 | — | 13,729 | ||
End of period undergraduate full-time active students | 13,129 | — | 13,129 |
For the Company's most recent investor presentation and quarterly financial supplement, please see its investor relations website at https://investor.uti.edu.
Conference Call
Management will hold a conference call to discuss the financial results for the fiscal 2023 first quarter ended
To participate in the live call, investors are invited to dial (844) 881-0138 (domestic) or (412) 317-6790 (international). A live webcast of the call will be available via the
Use of Non-GAAP Financial Information
In addition to disclosing financial results that are determined in accordance with
Adjusted EBITDA
For fiscal 2022, the Company defined adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation and amortization, adjusted for items not considered as part of the Company's normal recurring operations. Starting in fiscal 2023, the Company defines adjusted EBITDA as net income (loss) before interest expense, interest income, income taxes, depreciation and amortization, adjusted for stock-based compensation expense and items not considered normal recurring operations. Prior year amounts have been restated to include stock-based compensation expense.
Adjusted Free Cash Flow
The Company defines adjusted free cash flow as net cash provided by (used in) operating activities less capital expenditures, adjusted for items not considered normal recurring operations.
Adjusted Net Income (Loss)
The Company defines adjusted net income (loss) as net income (loss), adjusted for items that affect trends in underlying performance from year to year and are not considered normal recurring operations, including the income tax effect on the adjustments utilizing the effective tax rate.
We disclose any campus adjustments as direct costs (net of any corporate allocations). Management utilizes adjusted figures as performance measures internally for operating decisions, strategic planning, annual budgeting and forecasting. For the periods presented, this includes acquisition-related costs for both announced and potential acquisitions, integration costs for completed acquisitions, costs related to the purchase of our
Forward Looking Statements
All statements contained in this press release and the related conference call, other than statements of historical fact, are "forward-looking" statements within the meaning of the safe harbor from civil liability provided for such statements by the Private Securities Litigation Reform Act of 1995 (set forth in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). These forward-looking statements which address our expected future business and financial performance, may contain words such as "goal," "target," "future," "estimate," "expect," "anticipate," "intend," "plan," "believe," "seek," "project," "may," "should," "will," the negative form of these expressions or similar expressions. Examples of forward-looking statements include, among others, statements regarding (1) the Company's expectation that it will meet its fiscal year 2023 guidance for new student start growth (decline), revenue growth, Adjusted net income, Adjusted EBITDA and Adjusted Free Cash Flow; (2) expectation that it will continue to expand its value proposition and build a business that can grow in low-to-mid single digits with potential upside, regardless of the economic environment; (3) the Company's expectation that it will succeed in new campus launches next year; and (4) the Company's expectation of the successful integration of the Concorde acquisition. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of its business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could affect our actual results include, among other things, impacts related to the COVID-19 pandemic, changes to federal and state educational funding, changes to regulations or agency interpretation of such regulations affecting the for-profit education industry, possible failure or inability to obtain regulatory consents and certifications for new or modified campuses or instruction, potential increased competition, changes in demand for the programs we offer, increased investment in management and capital resources, failure to comply with the restrictive covenants and our ability to pay the amounts when due under the Credit Agreement with
Social Media Disclosure
About
Company Contact:
Chief Financial Officer
(623) 445-9365
Media Contact:
Vice President,
(623) 445-0872
Investor Relations Contact:
(312) 445-2870
UTI@alpha-ir.com
(Tables Follow)
| |||
Three Months Ended | |||
2022 | 2021 | ||
Revenues | $ 120,004 | $ 105,075 | |
Operating expenses: | |||
Educational services and facilities | 61,408 | 47,901 | |
Selling, general and administrative | 54,148 | 43,596 | |
Total operating expenses | 115,556 | 91,497 | |
Income from operations | 4,448 | 13,578 | |
Other income (expense): | |||
Interest income | 823 | 12 | |
Interest expense | (1,423) | (233) | |
Other income, net | 325 | 118 | |
Total other expense, net | (275) | (103) | |
Income before income taxes | 4,173 | 13,475 | |
Income tax (expense) benefit | (1,525) | 1,347 | |
Net income | 2,648 | 14,822 | |
Preferred stock dividends | (1,277) | (1,323) | |
Income available for distribution | 1,371 | 13,499 | |
Income allocated to participating securities | (514) | (5,267) | |
Net income available to common shareholders | $ 857 | $ 8,232 | |
Earnings per share: | |||
Net income per share - basic | $ 0.03 | $ 0.25 | |
Net income per share - diluted | $ 0.02 | $ 0.25 | |
Weighted average number of shares outstanding: | |||
Basic | 33,805 | 32,849 | |
Diluted | 34,408 | 33,572 |
| |||
Assets | |||
Cash and cash equivalents | $ 162,229 | $ 66,452 | |
Restricted cash | 4,542 | 3,544 | |
Held-to-maturity investments | — | 28,918 | |
Receivables, net | 22,252 | 16,450 | |
Notes receivable, current portion | 5,727 | 5,641 | |
Prepaid expenses | 11,422 | 6,139 | |
Other current assets | 8,871 | 8,809 | |
Total current assets | 215,043 | 135,953 | |
Property and equipment, net | 240,836 | 214,292 | |
26,992 | 16,859 | ||
Intangible assets, net | 18,895 | 14,215 | |
Notes receivable, less current portion | 30,767 | 30,231 | |
Right-of-use assets for operating leases | 199,947 | 132,038 | |
Deferred tax asset, net | 6,097 | 3,365 | |
Other assets | 9,496 | 5,958 | |
Total assets | $ 748,073 | $ 552,911 | |
Liabilities and Shareholders' Equity | |||
Accounts payable and accrued expenses | $ 62,855 | $ 66,680 | |
Dividends payable | 1,277 | — | |
Deferred revenue | 75,328 | 54,223 | |
Operating lease liability, current portion | 24,206 | 12,959 | |
Long-term debt, current portion | 1,945 | 1,115 | |
Other current liabilities | 3,601 | 2,745 | |
Total current liabilities | 169,212 | 137,722 | |
Operating lease liability | 195,730 | 129,302 | |
Long-term debt | 161,029 | 66,423 | |
Other liabilities | 4,816 | 4,067 | |
Total liabilities | 530,787 | 337,514 | |
Commitments and contingencies | |||
Shareholders' equity: | |||
Common stock, | 3 | 3 | |
Preferred stock, | — | — | |
Paid-in capital - common | 149,016 | 148,372 | |
Paid-in capital - preferred | 66,481 | 66,481 | |
(365) | (365) | ||
Retained earnings (deficit) | 64 | (1,307) | |
Accumulated other comprehensive income | 2,087 | 2,213 | |
Total shareholders' equity | 217,286 | 215,397 | |
Total liabilities and shareholders' equity | $ 748,073 | $ 552,911 |
| ||||
Three Months Ended | ||||
2022 | 2021 | |||
Cash flows from operating activities: | ||||
Net income | $ 2,648 | $ 14,822 | ||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||
Depreciation and amortization | 5,248 | 3,679 | ||
Amortization of right-of-use assets for operating leases | 4,120 | 4,472 | ||
Bad debt expense | 535 | 560 | ||
Stock-based compensation | 1,169 | 706 | ||
Deferred income taxes | 1,068 | (1,893) | ||
Training equipment credits earned, net | (83) | (147) | ||
Unrealized (loss) gain on interest rate swap | (126) | 173 | ||
Other (gains) losses, net | (143) | (148) | ||
Changes in assets and liabilities: | ||||
Receivables | 4,657 | 4,920 | ||
Prepaid expenses | (1,438) | (590) | ||
Other assets | 2,079 | (29) | ||
Notes receivable | (622) | (1,514) | ||
Accounts payable and accrued expenses | (15,925) | (8,367) | ||
Deferred revenue | 4,634 | (8,666) | ||
Operating lease liability | (4,963) | (2,567) | ||
Other liabilities | (46) | (2,955) | ||
Net cash provided by operating activities | 2,812 | 2,456 | ||
Cash flows from investing activities: | ||||
Cash paid for acquisitions, net of cash acquired | (16,973) | (26,142) | ||
Purchase of property and equipment | (6,782) | (10,792) | ||
Proceeds from maturities of held-to-maturity securities | 29,000 | — | ||
Return of capital contribution from unconsolidated affiliate | — | 75 | ||
Net cash provided by (used in) investing activities | 5,245 | (36,859) | ||
Cash flows from financing activities: | ||||
Proceeds from revolving credit facility | 90,000 | — | ||
Debt issuance costs related to the revolving credit facility | (484) | — | ||
Payments on term loans and finance leases | (273) | (216) | ||
Payment of payroll taxes on stock-based compensation through shares withheld | (525) | (301) | ||
Net cash provided by (used in) financing activities | 88,718 | (517) | ||
Change in cash, cash equivalents and restricted cash | 96,775 | (34,920) | ||
Cash and cash equivalents, beginning of period | 66,452 | 133,721 | ||
Restricted cash, beginning of period | 3,544 | 12,256 | ||
Cash, cash equivalents and restricted cash, beginning of period | 69,996 | 145,977 | ||
Cash and cash equivalents, end of period | 162,229 | 99,513 | ||
Restricted cash, end of period | 4,542 | 11,544 | ||
Cash, cash equivalents and restricted cash, end of period | $ 166,771 | $ 111,057 |
| ||||||||
Three Months Ended | ||||||||
UTI | Concorde | Corporate | Consolidated | |||||
Revenue | $ 105,573 | $ 14,431 | $ — | $ 120,004 | ||||
Total operating expenses | 89,058 | 15,157 | 11,341 | 115,556 | ||||
Net income (loss) | 15,825 | (734) | (12,443) | 2,648 | ||||
Three Months Ended | ||||||||
UTI | Concorde | Corporate | Consolidated | |||||
Revenue | $ 105,075 | $ — | $ — | $ 105,075 | ||||
Total operating expenses | 81,908 | — | 9,589 | 91,497 | ||||
Net income (loss) | 22,959 | — | (8,137) | 14,822 | ||||
Three Months Ended | ||||||||
UTI | Concorde | Corporate | Consolidated | |||||
Salaries, benefits and tax expense | $ 42,256 | $ 8,476 | $ 5,101 | $ 55,833 | ||||
Bonus expense | 3,543 | 188 | 1,134 | 4,865 | ||||
Stock-based compensation | 252 | — | 917 | 1,169 | ||||
Total compensation and related costs | $ 46,051 | $ 8,664 | $ 7,152 | $ 61,867 | ||||
Advertising expense | $ 13,349 | $ 1,280 | $ — | $ 14,629 | ||||
Occupancy expense, net of subleases | 8,026 | 1,764 | 125 | 9,915 | ||||
Depreciation and amortization | 4,775 | 457 | 16 | 5,248 | ||||
Professional and contract services expense | 3,065 | 97 | 2,175 | 5,337 | ||||
Three Months Ended | ||||||||
UTI | Concorde | Corporate | Consolidated | |||||
Salaries, benefits and tax expense | $ 37,919 | $ — | $ 4,889 | $ 42,808 | ||||
Bonus expense | 3,507 | — | 986 | 4,493 | ||||
Stock-based compensation | 169 | — | 537 | 706 | ||||
Total compensation and related costs | $ 41,595 | $ — | $ 6,412 | $ 48,007 | ||||
Advertising expense | $ 11,959 | $ — | $ — | $ 11,959 | ||||
Occupancy expense, net of subleases | 9,234 | — | 165 | 9,399 | ||||
Depreciation and amortization | 3,663 | — | 16 | 3,679 | ||||
Professional and contract services expense | 1,984 | — | 2,082 | 4,066 |
| |||||||
Reconciliation of Net Income to EBITDA and Adjusted EBITDA | |||||||
Three Months Ended | |||||||
UTI | Concorde | Corporate | Consolidated | ||||
Net income (loss) | $ 15,825 | $ (734) | $ (12,443) | $ 2,648 | |||
Interest income | (3) | (36) | (784) | (823) | |||
Interest expense | 881 | 44 | 498 | 1,423 | |||
Income tax expense | — | — | 1,525 | 1,525 | |||
Depreciation and amortization | 4,775 | 457 | 16 | 5,248 | |||
EBITDA | 21,478 | (269) | (11,188) | 10,021 | |||
Acquisition related costs | — | — | 775 | 775 | |||
Integration related costs for acquisitions | 219 | 150 | 726 | 1,095 | |||
Stock-based compensation expense | 252 | — | 917 | 1,169 | |||
Start-up costs for new campuses and program expansion | 1,324 | 55 | — | 1,379 | |||
Adjusted EBITDA, non-GAAP | $ 23,273 | $ (64) | $ (8,770) | $ 14,439 | |||
Three Months Ended | |||||||
UTI | Concorde | Corporate | Consolidated | ||||
Net income (loss) | $ 22,959 | $ — | $ (8,137) | $ 14,822 | |||
Interest income | (3) | — | (9) | (12) | |||
Interest expense | 233 | — | — | 233 | |||
Income tax (benefit) | — | — | (1,347) | (1,347) | |||
Depreciation and amortization | 3,663 | — | 16 | 3,679 | |||
EBITDA | 26,852 | — | (9,477) | 17,375 | |||
Acquisition related costs | — | — | 886 | 886 | |||
Integration related costs for acquisitions | 75 | — | — | 75 | |||
Stock-based compensation expense | 169 | — | 537 | 706 | |||
Start-up costs for new campuses and program expansion | 1,593 | — | — | 1,593 | |||
Adjusted EBITDA, non-GAAP | $ 28,689 | $ — | $ (8,054) | $ 20,635 |
| |||
Reconciliation of Net Income to Adjusted Net Income | |||
Three Months Ended | |||
2022 | 2021 | ||
Net income | $ 2,648 | $ 14,822 | |
Add back: Income tax expense (benefit) | 1,525 | (1,347) | |
Income before income taxes | 4,173 | 13,475 | |
Adjustments: | |||
Acquisition related costs | 775 | 886 | |
Integration related costs for acquisitions | 1,095 | 75 | |
Start-up costs for new campuses and program expansion | 1,379 | 1,593 | |
Adjusted income before income taxes | 7,422 | 16,029 | |
Income tax effect: (expense) benefit | (2,152) | (636) | |
Adjusted net income, non-GAAP | $ 5,270 | $ 15,393 | |
GAAP effective income tax rate (1) | 29.0 % | 4.0 % |
(1) | The GAAP effective tax rate for the three months ended |
Reconciliation of Net Cash Provided by Operating Activities to Adjusted Free Cash Flow | |||
Three Months Ended | |||
2022 | 2021 | ||
Net cash provided by operating activities, as reported | $ 2,812 | $ 2,456 | |
Purchase of property and equipment | (6,782) | (10,792) | |
Free cash flow, non-GAAP | (3,970) | (8,336) | |
Adjustments: | |||
Acquisition related costs paid | 594 | 1,190 | |
Integration related costs paid | 980 | 66 | |
Cash outflow for start-up costs for new campuses and program expansion | 1,379 | 267 | |
Cash outflow for property and equipment for new campuses and program expansion | 3,605 | 3,225 | |
Severance payment due to CEO transition | — | 32 | |
Adjusted free cash flow, non-GAAP | $ 2,588 | $ (3,556) |
View original content to download multimedia:https://www.prnewswire.com/news-releases/universal-technical-institute-reports-fiscal-year-2023-first-quarter-results-301742335.html
SOURCE
FAQ
What were UTI's Q1 FY2023 revenue figures?
How did UTI's net income perform in the latest quarter?
What is UTI's guidance for FY2024?
What impact did Concorde have on UTI's Q1 FY2023 results?